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I N T R O D U C T I O N
A variety of in vivo and in vitro recordings have shown convincingly that the membranes of cochlear hair cells of both mammalian and nonmammalian vertebrates possess voltagegated calcium channels and that these are important in regulating excitation of the auditory nerve fibers (Issa and Hudspeth 1994; Kollmar et al. 1997a,b; Robertson and Johnstone 1979; Siegel and Relkin 1987; Tucker and Fettiplace 1995; Zidanic and Fuchs 1995) . Such channels are known to have a variety of important roles. As in other secretory cells, when located close to the release sites for synaptic vesicles, they have been presumed to play a crucial role in controlling neurotransmitter release from the hair cells (Martinez-Dunst and Fuchs 1997; Roberts and Hudspeth 1990; Robertson and Johnstone 1979; Siegel and Relkin 1987) . In addition, voltage-gated calcium channels can regulate the conductance of the basolateral wall of the hair cells, principally through the action of Ca 2ϩ -activated potassium channels (Art and Fettiplace 1995; Dulon et al. 1998; Issa and Hudspeth 1994; Kimitsuki et al. 1998 ) and may also contribute to the regulation of other Ca 2ϩ -dependent aspects of hair cell function, including adaptation and slow contractile processes (Assad and Corey 1992; Ulfendahl 1987; Zenner et al. 1985) .
A wide variety of voltage-gated Ca 2ϩ channel subtypes have now been described that differ in their voltage dependence, conductance, and kinetic characteristics and in their pharmacological profile with respect to specific antagonists (for review, see Hofman et al. 1994; Miljanich and Ramachandran 1995; Tsien et al. 1991) . For a number of reasons it is of interest to know which of these subtypes is involved in each of the various stages of the complex process of cochlear transduction and activation of the primary afferent neurons.
Such knowledge could ultimately lead to the development of drugs targeted to different stages of transduction, and these could have utility in the treatment of a variety of inner ear disorders. With particular reference to the mammalian inner hair cells (IHCs), which constitute the major source of afferent neural outflow from the cochlea, it is known that different primary afferent neurons emanating from the same hair cells have different spontaneous firing rates, thresholds, adaptation characteristics, and dynamic ranges (Kiang et al. 1982; Muller and Robertson 1990; Winter et al. 1990) , and one hypothesis is that this diversity may be related to variations in a presynaptic property such as the type of voltage-gated Ca 2ϩ channel that controls transmitter release.
Recent molecular biological studies have revealed the presence of mRNAs coding for subunits of L-type channels in both mammalian and nonmammalian inner ear tissues (see, for example, Green et al. 1996 , Kollmar et al. 1997a . Furthermore, channels with kinetic and pharmacological characteristics typical of L-type channels (slow inactivation and susceptibility to the dihydropyridine class of blockers, such as nimodipine) have been demonstrated to be present in the hair cells of nonmammalian vertebrates. An intensive study of the effects of various blockers in chick cochlear hair cells (Zidanic and Fuchs 1995) indicates that this is the only channel type present in this species. In hair cells of the frog sacculus and semicircular canal, however, the presence of at least one other subtype (possibly N-type) in addition to L-type channels has been suggested (Prigioni at al. 1992; Su et al. 1995) . A variety of studies in bullfrog, chick, and turtle have shown that voltage-gated calcium channels are largely found at discrete sites in the hair cell membrane that colocalize with presynaptic dense bodies (the presumed sites of neurotransmitter release). However, although the circumstantial evidence is compelling, none of these studies on isolated hair cells has provided direct evidence for the control of neurotransmitter release by the L-type or any other specific subtype of Ca 2ϩ channel. In the intact mammalian cochlea, study of this question is complicated by the presence of two distinct sets of receptor hair cells with different but coupled roles in the transduction process. Briefly, the outer hair cells (OHCs) generate an AC receptor potential, the cochlear microphonic, and control the overall mechanoelectrical gain of the cochlea through their "active process" or "cochlear amplifier." The inner hair cells (IHCs) on the other hand, generate a DC receptor potential, the summating potential (SP), and provide the final excitation of most of the primary afferent neural output of the organ (for review see Robertson 1988, Yates et al. 1992) .
In a study in the guinea pig cochlea, Bobbin et al. (1990) provided good evidence that L-type channels are involved in various aspects of cochlear responses to sound. These workers demonstrated a series of complex changes in gross receptor potentials after perfusion with nimodipine (a specific L-type channel antagonist), that were consistent with an effect on the OHCs. However, they also showed a reduction in the maximum amplitude of the compound action potential (CAP) of the auditory nerve, suggesting an additional effect on the neural output from the IHCs (a decrease in gain alone mediated by OHC effects would not be expected to reduce the maximum neural output to high-level acoustic stimuli).
In the present study, we used gross recording techniques in the intact organ to pursue the specific question of the site of action of nimodipine and a T-type blocker Ni 2ϩ . We provide evidence to support the notion that L-type channels are involved in transmitter release from the IHCs, whereas T-type channels probably do not have a role in cochlear function.
M E T H O D S
Experiments were performed on young pigmented guinea pigs (260 -425 g) of either sex. All procedures conformed to the Code of Practice of the National Health and Medical Research Council of Australia and were approved by the Animal Experimentation Ethics Committee of The University of Western Australia.
Animals were anesthetized according to previously published procedures (Lowe and Robertson 1995) . A small hole drilled in the basal turn scala tympani was used for insertion of a perfusion pipette (ϳ80 m tip diam), which was sealed in place with a small bead of Sylgard attached to the shank of the pipette. The perfusion outlet hole was made in the cochlear apex, and great care was taken to prevent bleeding from this hole to eliminate the possibility of blockage of the perfusion by blood clots. Perfusion was performed at a rate of 3 lmin Ϫ1 for 10 min. The control artificial perilymph comprised (in mM) 137 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 1 NaH 2 PO 4 , 12 NaHCO 3 , and 10 glucose. The solution pH was adjusted to 7.4 at 37°C with the addition of 1 M NaOH.
Drugs were dissolved in the artificial perilymph without modifying the solution composition. Nimodipine (Alomone Laboratories) was dissolved first in DMSO, the final concentration of which in the perfusion solution ranged from 0.1 to 0.01% when nimodipine concentration ranged from 10 to 1 M. TTX was obtained from Calbiochem-Behring, and all other salts and chemicals were obtained either from Sigma or BDH Chemicals.
The perfusion pipette served also to house a fine, etched platinum wire electrode for recording sound-evoked cochlear potentials. Figure  1 illustrates the perfusion and recording arrangement. The reference electrode was a chlorided silver wire inserted in the animals' neck muscles. Gated tone bursts (10-ms duration with 1-ms rise-fall times, repetition rate 10 s Ϫ1 ) were delivered through a closed, calibrated sound delivery system. The sound-evoked potentials measured from the recording electrode were amplified and filtered before display on an oscilloscope screen and storage on computer disk.
A number of measures of the sound-evoked potentials were obtained and used in subsequent analysis. Direct observation from an oscilloscope screen was used to measure the visual detection threshold of the first negative wave (N 1 ) of the nerve fiber CAP and the negative DC receptor potential (SP) to tone bursts ranging in frequency from 2 to 30 kHz (Fig. 1C) . Note that the sign of the SP is traditionally denoted by its sign in the scala media, which is generally the reverse of that measured in the scala tympani.
Repeated blind measures of the visual detection thresholds for the CAP and the SP at a variety of sound frequencies indicated that these were reliable to within Ϯ3 dB for any one observer (see also Johnstone et al. 1979; Rajan et al. 1991) . Also measured were the amplitude of the CAP (N 1 -P 1 peak-to-peak amplitude) and the SP (DC shift from baseline at 8 ms after tone onset) at a range of stimulus intensities. These measures were derived from off-line analysis of computer-generated averaged responses to 10 stimulus presentations.
A separate group of animals had their OHCs destroyed throughout much of the basal cochlear turn by administration of the ototoxic antibiotic kanamycin. Animals were injected intraperitoneally with a solution of kanamycin sulfate (Sigma) dissolved in saline at a dose of 400 mg/kg for 10 days (Dallos and Harris 1978; Dallos and Wang 1974) . They were then allowed to recover for ϳ2 weeks before final experimentation. At the end of the experiments, cochleae were fixed by perfusion with 2.5% glutaraldehyde in 0.1 M phosphate buffer, postfixed with 1% osmium tetroxide in phosphate buffer, and dissected, and surface mounts were prepared for inspection of missing hair cells.
R E S U L T S

Control perfusions
Perfusion of the scala tympani with artificial perilymph caused very small changes in all measures of CAP and SP responses. Typically, there was a depression of ϳ3 dB in the threshold measures in the first 1-2 minutes of perfusion, but these rapidly recovered. We interpret the early and reversible change in thresholds to be a response to minor hydrostatic pressure changes in the cochlea at the onset of perfusion. When the mean visual detection thresholds of the CAP and SP to a 10-kHz tone burst were compared before and at the end of a 10-min perfusion the changes were Ͻ2 dB (n ϭ 25 for CAP and n ϭ 20 for SP). These changes were within measurement error and were not considered statistically significant (P Ͼ 0.05 for both CAP and SP). Input-output functions derived from averaged response waveforms at a range of intensities also showed no significant change after 10 min of artificial perilymph perfusion (Fig. 2, A-C) .
Perfusions with artificial perilymph containing 0.1% DMSO (the solvent used for nimodipine) also had no significant effects on CAP and SP thresholds. Similar to the standard artificial perilymph perfusion, the average change in thresholds at the end of a 10-min perfusion was Ͻ2 dB (n ϭ 5) for both electrophysiological responses.
Nickel perfusions
In five animals, the cochlea was perfused with artificial perilymph containing 100 M Ni 2ϩ . The effects of these perfusions did not differ significantly from control perfusions, showing no significant difference in the 10-kHz CAP and SP visual detection thresholds or in their respective input-output functions at the end of a 10-min perfusion. (Fig. 3, A-C ).
Nimodipine perfusions: normal cochleas
In contrast to the results obtained with both artificial perilymph and artificial perilymph containing 100 M Ni 2ϩ or 0.1% DMSO, perfusion with artificial perilymph containing 0.01-0.1% DMSO and nimodipine at concentrations ranging from 1 to 10 M, respectively, caused marked changes in CAP and SP visual detection thresholds and input-output curves. For concentrations of nimodipine Յ3 M, the effects were generally reversible over a period of tens of minutes after the cessation of perfusion, and this reversibility could be accelerated by reperfusion with control perilymph. At concentrations of Ͼ3 M, reversibility was very slow and could not always be demonstrated. Figure 4 shows the effects on CAP inputoutput curves for two frequencies of tone burst, 10 kHz and 20 kHz. Similar to the results obtained by Bobbin et al. (1990) for 10-kHz stimulation, there was a shift to the right in the curves and a reduction in the maximum CAP amplitude for both frequencies.
To quantify the relationship between CAP and SP threshold changes, we used 20-kHz tone burst stimulation in preference to 10 kHz, because the recording electrode was placed near the high-frequency end of the cochlea in the basal turn scala tympani immediately adjacent to the round window. It is known that whereas CAP recordings of tone bursts are relatively unbiased by electrode location , the SP recording is more localized and, particularly near threshold, reflects to a large extent the cellular responses in the immediate vicinity of the recording electrode (Cheatham and Dallos 1984) . Therefore, a 10-kHz tone would faithfully probe the neural sensitivity of the 10-kHz region of the cochlea, but the SP recording would be contaminated by cellular responses from more basal regions in the immediate vicinity of the recording electrode. The results in Fig. 5 , A-D, show that the shift in visual detection threshold produced by nimodipine is strikingly less for the SP than for the CAP. The average CAP threshold changes were 16, 30, and 49 dB in 1, 3, and 5 M nimodipine, respectively. This contrasted with changes of only 10, 12, and 15 dB in the respective average SP thresholds. An action of nimodipine restricted to the OHC active process would affect the overall cochlear gain and would therefore be expected to cause equivalent changes in CAP and SP threshold. The result shown in Fig. 5 is therefore not consistent with a pure OHC effect. Rather, the proportionately greater effect on the CAP threshold suggests a dominant action of nimodipine on the final stage of nerve fiber excitation (the IHC-afferent nerve fiber synapse). Robertson and Johnstone (1979) ]. C: example of the combined gross potential waveform recorded from the sala tympani of the first turn of the guinea pig cochlea in response to a suprathreshold tone burst (10 kHz, 10-ms duration, 1-ms rise-fall time). Tone burst turned on at 0 ms. Compound auditory potential (CAP) and summating potential (SP) components of the waveform are identified. The AC receptor potential (cochlear microphonic) was largely filtered out by the bandpass filter of the recording system.
Salicylate perfusions
It was important to test the validity of our technique of measuring corresponding CAP and SP thresholds as a means of dissecting the possible sites of action of nimodipine. We therefore chose to repeat the basic measurements with intracochlear perfusion of salicylate, a drug known to affect the OHC active process selectively (Fitzgerald et al. 1993; Stypulkowski 1990) . Three animals were perfused with artificial perilymph containing 10 mM salicylate, and the SP and CAP thresholds were measured for 20-kHz acoustic stimuli before and during the perfusion. It can be clearly seen from the data presented in Fig. 6 that in contrast to the nimodipine result, CAP and SP changes caused by salicylate were essentially identical over a wide range. This result shows that the technique can distinguish between drug actions that affect the OHC active process and those that affect other stages of the transduction chain.
Nimodipine perfusions: kanamycin animals
Although nimodipine caused a markedly greater change in CAP than SP threshold, which points to a dominant action on stages of transduction after the OHC active process, there was still a significant SP threshold change caused by all concentrations of nimodipine. In an attempt to determine the cause of this change in another group of animals, the OHCs over a restricted region of the cochlea were destroyed by prior administration of kanamycin. Figure 7 shows examples of the CAP thresholds from 2 to 30 kHz (so-called CAP audiograms) obtained in animals administered kanamycin, compared with the average CAP audiograms in normal animals. There was considerable variability in the effects of kanamycin, but in all cases, there was a marked elevation of the CAP threshold at high frequencies. This correlated with the degeneration of OHCs confirmed in subsequent histology (results not shown). It is well established from previous work that CAP sensitivity losses of Ն50 dB are to be expected in regions of the cochlea with total loss of OHCs (Patuzzi and Rajan 1992) .
We managed to obtain six animals in which the threshold loss at 20 kHz was ϳ40 -60 dB (absolute threshold ϳ80 dB sound pressure level). The average threshold change at 20 kHz was 49 dB. Despite these greatly elevated thresholds caused by OHC destruction, when nimodipine perfusions were performed in these animals, CAP and SP threshold changes were still observed. Only a small number of perfusions using 5 M nimodipine were performed, and the data shown in Fig. 8 , A-C, are for perfusions with 1-3 M only. As shown in Fig. 8 , CAP threshold changes were comparable to those produced by the same concentrations of nimodipine in normal animals. On the other hand, the SP threshold changes were significantly less. whereas in kanamycin-treated animals, the threshold changes were 29 dB for the CAP and only 7 dB for the SP. When data from 1-and 3-M perfusions were pooled (n ϭ 10), the difference between CAP threshold changes in the normal and kanamycin groups were not significant (P Ͼ 0.95), whereas the differences in SP threshold changes were important (P Ͻ 0.05). This result suggests, first, that the CAP threshold changes caused by nimodipine are not dependent on intact OHCs and, second, that a substantial portion of the SP threshold change seen during nimodipine perfusion in the normal cochlea is somehow caused by an action of nimodipine on the OHCs.
In an attempt to deduce how much of the small nimodipine-induced SP threshold change that still remained after OHC destruction was caused by contamination of the SP recording by neural, rather than hair cell activity, we performed experiments in five kanamycin animals using perfusion with TTX (1 M) to eliminate action potentials by blockage of voltage-gated Na ϩ channels (Narahashi 1974) . The success of TTX in blocking all neural activity was assessed by the complete disappearance of the CAP. Subsequent nimodipine perfusion (3-M concentration) caused almost no change in the SP thresholds or input-output curves. The mean SP threshold change caused by nimodipine after TTX was only 2 dB (n ϭ 5). This was within measurement error, and, when compared with the mean SP threshold change when TTX was not present, the difference was highly significant (P Ͻ 0.001)
The effects of nimodipine on SP thresholds in the various experimental groups are compared in Fig. 9 , which shows the average 20-kHz SP threshold change observed after 10 min of 3 M nimodipine perfusion (n ϭ 5 for each group of animals). SP threshold changes caused by nimodipine were greatest in normal animals, were reduced substantially by loss of OHCs, and were insignificant when neural activity was blocked by TTX.
D I S C U S S I O N
These results show that under particular conditions, an Ltype Ca 2ϩ channel blocker can cause changes in the gross neural potentials (CAP) in the cochlea that are more or less dissociated from the major DC receptor potential (SP). We interpret this result to mean that this blocker is acting on the IHC-afferent nerve fiber synapse. Figure 10 shows schematically the logic behind this conclusion. As the figure attempts to show, an effect of nimodipine on the OHCs alone would be expected to cause proportional alterations in SP and CAP thresholds through an effect on the gain of mechanical drive to the IHCs. This expected result was obtained using salicylate, which is well known to affect the OHC active process. On the other hand, an action restricted to the final stages of neural excitation at the base of the IHCs should lead to a greater change in CAP than SP thresholds (some small effect on SP thresholds might still be expected, as shown in the Fig. 10 , if there were a second-order effect on OHCs as well). A result approximating this latter prediction was seen when a 20-kHz tone was used, and agreement with the prediction was even better when OHCs were removed by the use of kanamycin. Finally, it was shown by the use of TTX that the small residual SP threshold change caused by nimodipine in the absence of OHCs was probably due to contamination of the SP response by neural activity.
We believe these results constitute evidence that L-type Ca 2ϩ channels exert a major and direct controlling influence on one of the final stages of transduction in the inner ear. Given the association of voltage-gated Ca 2ϩ channels with transmitter release sites in other hair cell systems, we feel it is most likely that these L-type channels control the influx of Ca 2ϩ at specific presynaptic release sites located around the basolateral pole of the inner hair cells.
The possibility should be considered that nimodipine may produce these effects in other ways than through blockage of voltage-gated Ca 2ϩ channels at the presynaptic locus of vesicle exocytosis from the IHCs. For example, it is possible that the action could be exerted postsynaptically on the primary afferent dendrites. However, the fact that TTX virtually eliminates the CAP suggests that voltage-gated Ca 2ϩ channels in the auditory dendrites do not contribute a major component to postsynaptic currents recorded by our techniques. The possibility should also be considered that nimodipine may alter the standing current through the IHCs, perhaps by changing the large DC endocochlear potential (EP) known to be present in the scala media (Sellick and Johnstone 1972). Bobbin et al. (1990) have reported that nimodipine perfusion, if it produces any change in the EP, does so by only a few millivolts (a mean decrease in EP of 3 mV). This would have a trivial effect on the overall electrochemical driving force of some 130 -140 mV across the IHC transduction channels but could have a significant effect on evoked transmitter release depending on the precise relationship between IHC membrane potential and exocytosis. Sewell (1984) has reported that single afferent fiber acoustic thresholds change by ϳ1 dB for every millivolt change in EP, which suggests that any change in gross thresholds caused by such an effect of nimodipine would be probably within measurement error.
Alternatively, nimodipine may affect the IHC mechanoelectrical transduction process or the IHC membrane potential. The most plausible mechanism for such an effect would be an indirect one, through Ca 2ϩ -activated K ϩ channels. Although such channels have been extensively described in nonmammalian hair cells, the available evidence suggests that if they exist in mammalian inner hair cells, they are not gated by Ca 2ϩ entry through the plasma membrane (Dulon et al. 1995; Kros and Crawford 1990) . We believe that these possibilities are inconsistent with our findings in kanamycin-treated animals, because in the kanamycin-treated cochlea poisoned with TTX, the SP observed should be purely derived from the IHCs; therefore, the absence of effect of nimodipine on the SP indicates that it has little or no action at the level of IHC transduction.
Despite our contention that the results presented in this study are consistent with involvement of L-type channels at the IHC-afferent nerve fiber synapse, L-type channels may also be involved in OHC function. Certainly, dihydropyridine-sensitive channels have been demonstrated in OHCs using other methods (Chen et al. 1995) . Some aspects of our own data are also consistent with this notion. For example, the 20-kHz SP threshold change caused by nimodipine was substantially reduced when the OHCs were destroyed in this region of the cochlea. This implies that nimodipine may alter the OHC gain as well as act at the IHC synapse. Second, we found in one group of normal animals, by using 10-kHz stimulation, that TTX perfusion did not eliminate the effect of nimodipine on the SP (results not shown). Thus, neural contamination of the SP recording cannot fully account for the observable SP threshold change caused by blockage of L-type channels when the OHCs are present. Finally, although we have not reported the results in detail in this article, we have confirmed the observation by Bobbin et al. (1990) that certain concentrations of nimodipine can cause a reversal in the polarity of the SP at some sound pressure levels. This was most evident for 10-kHz stimulation at sound pressures ϳ80 dB SPL and in the presence of 5 M nimodipine. We observed it only rarely and inconsistently for 20-kHz stimulation. A possible explanation for this reversal of SP is that nimodipine may cause the OHCs to generate a substantial SP of opposing polarity to the IHCs. The possibility that OHCs may generate an abnormal and reversedpolarity SP in the presence of nimodipine provides a possible explanation for the fact that SP changes caused by nimodipine are less in kanamycin-treated animals compared with normal subjects, whereas the CAP threshold changes are the same. The SP threshold change in the presence of OHCs may not reflect a gain change caused by nimodipine, but the addition of negative and positive contributions to the SP from the two sets of receptor cells. If this is correct, it would add even more weight to the notion that nimodipine produces changes in neural sensitivity (CAP threshold) by an action on the IHCafferent synapse.
There are a number of outstanding questions with regard to the identity of the channels involved both in IHCs and OHCs. The IHC resting potential is between Ϫ40 and Ϫ50 mV (Russell and Sellick 1978) and the maximum depolarization in response to nondamaging levels of sound has been reported to be ϳ10 mV (Patuzzi and Sellick 1983) . Thus, the least negative value of membrane potential expected in these cells is well below the normal operating range of classic L-type channels (Tsien et al. 1991) , and therefore, although the channels are, similar to classic L-type channels, blocked by nimodipine, they are clearly unusual in their voltage dependence. Recent molecular biological studies on calcium channels in chick (Kollmar et al. 1997a,b) and mouse (Green et al. 1996) suggest strongly that alternative splicing of mRNAs encoding for one or more of the subunits of the L-type channel may be an explanation for this unusual voltage-sensitivity of the nimodipine-sensitive channels in the inner ear. A similar situation may exist in vertebrate photoreceptors in which membrane potentials of Ϫ35 to Ϫ40 mV lead to constant calcium-dependent release of transmitter in the dark (Schmitz and Witkovsky 1997; Wilkinson and Barnes 1996) .
From gross potential measurements we cannot say that only L-type channels are involved in the IHC. There is a diversity of single primary afferent fiber characteristics, in spontaneous rates, thresholds, and adaptation characteristics, and we cannot exclude the possibility that a small subgroup of primary afferents has their excitation controlled by other subtypes of presynaptic calcium channel. For example, highly sensitive neurons with rapid adaptation may be controlled by hair cell channels with characteristics more akin to T-type than L-type. In the present experiments, we attempted to test this notion using the selective T-type channel blocker Ni 2ϩ , but could see no effect on either CAP or SP, even though the concentrations used were well in excess of those known to block T-type channels in other systems (Fox et al. 1987 ). This result, however, is largely inconclusive, because an Ni 2ϩ -sensitive subgroup of neurons may be insufficient in number to contribute significantly to the gross neural response. Furthermore, we have not yet tried perfusion with specific blockers of other types of Ca 2ϩ channels, such as the various conotoxins and agatoxins, which are selective for N-, P-, and Q-type channels. Such future experiments seem important in view of the evidence suggesting that N-type channels may operate in addition to L-type channels in hair cells of the frog sacculus and crista ampullaris (Prigioni et al. 1992; Su et al. 1995) . In addition, the gross potential measurements reported in the current study cannot tell us whether L-type channels control the spontaneous release of transmitter from IHCs and the background firing rates of the auditory afferent neurons, although perfusion with nonspecific Ca 2ϩ channel blockers have clearly shown that the spontaneous discharge of single auditory afferents is under the control of Ca 2ϩ channels. Further experiments will be required to address these latter issues.
